Rezan Koçak Ulucaköy, et al. “Can Serum Granulocyte-Macrophage Colony-Stimulating Factor and CCL17 Levels Be a Marker of Disease Activation in Spondyloarthritis?”. Archives of Rheumatology, vol. 39, no. 3, Sept. 2024, pp. 368-74, doi:10.46497/ArchRheumatol.2024.10360.